… technologies to tackle the COVID-19 pandemic have been … pathophysiology and cardiovascular
implications of COVID-19, its … implications of myocardial injury in patients with COVID-19. …

… In this article, we summarize current recommendations for diagnosing and managing patients
with COVID-19. Although this information is current up to March 2020, we anticipate that …

… Between 8% and 28% of patients with COVID-19 infections will manifest troponin release
early in the course of the disease, reflecting cardiac injury or stress. The presence of troponin …

… The mean age of patients in the control group was 66.8 yr (range 49–75 yr), which was not
… COVID-19 patients (p = 0.807, Student t test). The mean number of Leydig cells in COVID-19 …

… list of screening tools for possible COVID-19 infection. Mild neurological symptoms, …
COVID-19 patients. In addition, the most common (52%) symptoms of adult patients with COVID-19 …

… , complement-mediated thrombotic microangiopathy (TMA) is surprisingly common in
patients with coronavirus disease 19 (COVID-19). Like the better known TMA syndromes, this …

… immune responses and COVID-19 trajectory, we stratified the COVID-19 patients (n = 125) …
from COVID 1 (death) and COVID 2 (requiring maximal clinical intervention) to COVID 8 (at …

… A study of a cohort of 138 patients from a hospital in Wuhan … 402 COVID-19 patients showed
significantly higher mortality in male than female patients, and a mortality of 19% in patients …

… of 187 patients with COVID-19, 27.8% of patients had myocardial … outcome of COVID-19,
while the prognosis of patients with … Meaning It is reasonable to triage patients with COVID-19 …

… Neutralizing antibody titers of these participants were similar to the convalescent sera from
COVID-19 recuperated patients [21]. Higher age adults subjects who received two doses of …